Medical Capital Equipment & Infrastructure Consulting
Can your capital assets unlock $50 million + in lifecycle value and deliver 25% higher utilization?
Partners
Who Trust Us
Scalable, Future-Ready Healthcare Infrastructure through Strategic Insight
Medical capital equipment is evolving from a procurement decision into a strategic driver of healthcare performance. As providers prioritize digital integration, asset utilization, and long-term operational efficiency, investment decisions increasingly focus on lifecycle value rather than acquisition alone. U.S. hospitals are running on aggregate margins of 1.6%, and with FDA
clearing 275 new AI/ML-powered devices, digital integration is now the foundation for competitive positioning.
As healthcare systems balance infrastructure modernization, cost pressures, and regulatory complexities, Stellarix is helping companies streamline product and service portfolios, enhance asset performance, and build future-ready infrastructure ecosystems to drive sustainable growth.
Asset Lifecycle Optimization
Smart Hospitals
Decentralized Care Delivery
Service-Led Business Models
CapEx Rationalization
Core Focus Areas
Helping leaders translate scientific breakthroughs into scalable therapeutic opportunities.
Point-of-Care & Decentralized Diagnostics
The center of gravity in diagnostics is shifting toward distributed care environments, where speed, accessibility, and clinical efficiency are driving adoption. We help clients identify high-value diagnostic opportunities, develop commercialization strategies, and optimize product portfolios to accelerate adoption across decentralized care settings.
Molecular, Precision & Advanced Diagnostics
Precision diagnostics is becoming the foundation of personalized medicine as companion diagnostics and molecular testing continue to expand. We are assisting companies in identifying emerging technologies, developing evidence-based strategies, and optimizing precision diagnostic portfolios to maximize commercial and clinical value.
Connected Monitoring & Wearable Technologies
Remote monitoring is transforming healthcare by enabling continuous patient engagement beyond traditional care settings. We support organizations in optimizing digital health portfolios, developing scalable monitoring strategies, and prioritizing connected care investments that improve clinical and business outcomes.
AI-Enabled Diagnostics & Clinical Intelligence
AI is becoming an integral part of diagnostics through predictive analytics, clinical decision support, and medical imaging. We help organizations identify AI-driven growth opportunities, develop commercialization strategies, and evaluate technology investments to accelerate clinical adoption.
Digital Therapeutics & Bioelectronic Medicine
Software-driven therapies and bioelectronic medicine are reshaping treatment pathways while evolving regulatory frameworks improve market readiness. We are helping organizations prioritize investments, evaluate commercialization opportunities, and develop strategies that accelerate adoption and maximize long-term value.
Need Strategic Guidance for Your Business?
Strategic Hurdles of Medical Capital Equipment
Structural pressures reshaping the capital equipment & infrastructure businesses by impacting utilization, profitability, and long-term scalability.
Underutilization of High-Value Assets
Acquisition of new equipment is rarely the problem, but extracting full value from existing assets is. Across U.S. healthcare systems, MRI and CT machines utilization averages just 55-60%, while that of robotic surgical systems stands at 45-50%. Rather than the demand itself, the constraint lies in patient flow, scheduling logic, and capacity planning.
Cost Pressures and CapEx Constraints from Buyers
Capital budgets are tightening and exhaust long before the demand for technology slows down. While medical equipment prices increased by 4.1%, hospitals continue to work at 1.6% aggregate margins. This is compelling procurement teams to scrutinize every single investment through a lifecycle value lens.
Expanding Access Across Diverse Care Settings
The next chapter of capital equipment growth wouldn’t come from large academic hospitals alone. Expansion of ambulatory care, encouraged by 33.8 million Medicare Advantage beneficiaries and 27 new ASC procedure codes, is increasing the demand for equipment that can operate across more diverse care environments. Companies adopting localized platform strategies are achieving 35-40% faster adoption and $15-20 million in incremental revenue.
Transitioning to Service-Led & Outcome-Based Models
Hardware sales are rapidly becoming the initiating point of the customer relationship and not the endpoint. As the medical equipment maintenance market surpasses $50 billion and service contracts account for ~30% of revenue for market leaders, long-term value shifts towards lifecycle services. But the transition demands different commercial capabilities, pricing structures, and customer engagement models.
Ensuring Uptime and Service Reliability at Scale
For healthcare providers, equipment reliability is measured less by engineering performance than by continuous clinical operations. Every hour of unplanned downtime costs companies approximately $1000-$1,500. Additionally, 96 FDA Class I and II recalls in 2025 reinforced operational risks related to equipment failure.
Managing Supply Chain Complexity and Installation Delays
Commercial success is increasingly being determined after the purchase orders are signed. Component shortages, installation delays, and site readiness are turning into major constraints with increasing technical and integration complexities.
How We Drive Client Impact
See how we turn market signals into strategic clarity for the challenges that matter most.
Mounting uncertainty from emerging technologies, stringent clinical evidence requirements, and a fragmented startup ecosystem are redefining innovation in the MedTech industry.
By integrating innovation strategy, IP advisory, and technology intelligence, we are helping businesses drive business model innovation, evaluate clinical evidence, and optimize development roadmaps to de-risk investments and accelerate commercialization effectively.
We evaluate markets, customers, pricing, and partnerships to shape growth priorities and expansion pathways. Our capabilities encompass market assessment, market segmentation, growth opportunity analysis, and strategic alliances.
We develop decarbonization and circular economy strategies that connect resource efficiency and resilience with commercial objectives and long-term value creation.
Our work includes margin analysis, pricing and cost scenarios, portfolio exposure, supplier benchmarking, and alternative sourcing to support operational decisions.
Stellarix integrates early-warning monitoring, regulatory assessment, and future-state scenarios to inform mitigation, preparedness, and investment decisions.
Our expertise includes evaluating customer and stakeholder needs, reimbursement factors, value propositions, positioning, and commercialization strategies to identify effective market-entry approaches.
Stellarix unifies MedTech data, value chain reports, device registries, deal tracking, funding, and expert insights, enabling rapid and confident decisions.
Explore more in the MedTech Industry
Discover how precision diagnostics, connected care, and next-generation medical technologies are reshaping healthcare infrastructure, clinical adoption, and competitive positioning.
Outcomes That Speak for Themselves
A leading diagnostics company sought to expand into the at-home testing segment, targeting aging populations…
A market leader in surgical robots engaged Stellarix to enhance its orthopaedic portfolio and value…
The ophthalmic medical device industry is evolving rapidly, driven by digital transformation and sustainability goals.…